<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00692952</url>
  </required_header>
  <id_info>
    <org_study_id>China FDA 2003L02778</org_study_id>
    <secondary_id>ISRCTN16203579</secondary_id>
    <nct_id>NCT00692952</nct_id>
  </id_info>
  <brief_title>Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial</brief_title>
  <acronym>BZK</acronym>
  <official_title>Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Institute of Planned Parenthood Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Municipal Commission of Population and Family Planning</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Peace Maternity and Child Health Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai No. 1 Maternity and Child Care Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chang Jiang Bio-pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Institute of Planned Parenthood Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multicentric clinical trial in three Chinese Maternal and Child Hospitals was conducted to
      evaluate the efficacy, safety and acceptability of newly-developed vaginal contraceptive gel,
      the optimized benzalkonium chloride (BZK) gel containing 18mg BZK, with comparison to a
      currently marketed (in China)contraceptive gel LELEMI® containing 50mg Nonoxynol-9 (N-9).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A phase II, multicentric,randomized, controlled clinical trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2004</start_date>
  <completion_date type="Actual">November 2005</completion_date>
  <primary_completion_date type="Actual">November 2005</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>contraceptive efficacy</measure>
    <time_frame>March 2004 - November 2005</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>acceptability</measure>
    <time_frame>March 2004 - November 2005</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>120 subjects using BenZalkonium Chloride Contraceptive Gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>120 subjects using Nonoxynol-9 contraceptive gel</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>a novel Benzalkonium Chloride (BZK) contraceptive gel</intervention_name>
    <description>insert 1 piece of the gel (containing 18mg BZK) into vagina before every coital act.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LELEMI® contraceptive gel containing 50mg nonoxynol-9</intervention_name>
    <description>insert 1 piece ofLELEMI® contraceptive gel within half an hour before every coital act</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at risk for pregnancy and desiring contraception

          -  having regular menstrual cycle (21-35 days)

          -  at low risk for HIV or other sexually transmitted infection

          -  sexually active

          -  use the test products as their primary method of contraception

          -  keep a diary of coital activity, product use, and adverse events

        Exclusion Criteria:

          -  diagnosis of any vaginal infection or any symptom of STDs at baseline

          -  known allergy or hypersensitivity to N-9 or BZK

          -  menopause for more than one month

          -  breastfeeding

          -  vaginal bleeding with unknown reasons

          -  genitourinary system anomaly

          -  hysteroptosis II or severe cystocele

          -  moderate to severe erosion of cervix

          -  malignant reproductive system tumors
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jinxun XU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Municipal Commission of Population and Family Planning</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gynecology and Obstetrics Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>International Peace Maternity and Child Care Center</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai No. 1 Maternity and Child Care Center</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2008</study_first_submitted>
  <study_first_submitted_qc>June 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2008</study_first_posted>
  <last_update_submitted>July 9, 2009</last_update_submitted>
  <last_update_submitted_qc>July 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Xuncheng DING</name_title>
    <organization>Shanghai Institute of Planned Parenthood Research</organization>
  </responsible_party>
  <keyword>contraceptive efficacy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
    <mesh_term>Nonoxynol</mesh_term>
    <mesh_term>Benzalkonium Compounds</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

